Mulmit

NRX Pharmaceuticals, Inc.NRX Pharmaceuticals, Inc.

NRXP Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,225,000-16,224,000-28,622,000
2024-12-310-18,502,000-25,126,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-01-27Casper Joseph MichaelChief Operating Officer100,000
2025-04-09Javitt Jonathan CChairman and Chief Scientist125,000
2025-04-09McBride Dennis25,000
2025-04-09Hurvitz Chaim25,000
2025-04-09Flynn Patrick John50,000
2025-02-07ABRAMS MICHAEL SChief Financial Officer50,000
2024-12-17Javitt Jonathan CChairman and Chief Scientist40,000
2023-08-30Gorovitz Aaron35,000
2023-08-30Hurvitz Chaim70,000
2023-08-23Javitt Jonathan CChief Scientist100,000
2023-08-22Javitt Jonathan CChief Scientist200,000
2022-12-16Willard Stephen HCHIEF EXECUTIVE OFFICER50,000

8-K events

FiledItems
2026-09-16Other events · Financial statements and exhibits
2026-09-14Regulation FD disclosure · Financial statements and exhibits
2026-08-17Results of operations · Financial statements and exhibits
2026-08-07Regulation FD disclosure
2026-07-22Other events
2026-06-04Entry into a material agreement · Other events · Financial statements and exhibits
2026-06-02Other events · Financial statements and exhibits
2026-03-24Officer or director change · Submission of matters to a vote · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.